Aerosolized Ad5-nCoV

BIOLOGICAL2 trials

Sponsors

Jiangsu Province Centers for Disease Control and Prevention

Conditions

COVID-19

Phase 3

Heterologous Boost Immunization with an Aerosolised Ad5-nCoV After Two-dose Priming with an Inactivated SARS-CoV-2 Vaccine

CompletedNCT05204589

Jiangsu Province Centers for Disease Control and PreventionCOVID-19

Start: 2022-01-22End: 2022-10-27Updated: 2025-02-21

Phase 4

Effectiveness of a Second COVID-19 Vaccine Booster in Chinese Adults

Jiangsu Province Centers for Disease Control and PreventionCOVID-19

Start: 2023-05-18End: 2024-12-31Target: 10000Updated: 2023-05-22

Related Papers

Effectiveness of a booster dose of aerosolized or intramuscular adenovirus type 5 vectored COVID-19 vaccine in adults: a multicenter, partially randomized, platform trial in China.

2025-03-263 citations

Safety, immunogenicity and protection of heterologous boost with an aerosolised Ad5-nCoV after two-dose inactivated COVID-19 vaccines in adults: a multicentre, open-label phase 3 trial.

2023-06-2039 citations